Literature DB >> 27808034

Iodine deficiency in pregnancy is prevalent in vulnerable groups in Denmark.

Ditte Marie Kirkegaard-Klitbo1, Kathrine Perslev, Stine Linding Andersen, Hans Perrild, Nils Knudsen, Tom Weber, Lone Banke Rasmussen, Peter Laurberg.   

Abstract

INTRODUCTION: Iodine is essential for the production of thyroid hormones. In pregnancy, physiological changes occur that can lead to iodine deficiency and impairment of fetal neurological development. We aimed to assess the iodine intake in pregnant women in Eastern Denmark, compare iodine levels in Eastern and Western Denmark and to identify potentially vulnerable groups.
METHODS: This was a cross-sectional cohort study of pregnant Danish women (n = 240). Questionnaires and urine samples were collected at the Ultrasound Clinic, Hvidovre Hospital, Denmark, and urinary iodine concentrations (UIC) (µg/l) were measured. Predictors of iodine supplement use were examined by multivariate logistic regression models.
RESULTS: The pregnant women from Eastern Denmark had a median age of 30 years and the median gestational week at which they were included in the study was week 19. The majority took iodine-containing supplements (86%). The median UIC was 118 (interquartile range (IQR): 79-196) µg/l in iodine supplement users and 82 (IQR: 41-122) µg/l in non-users (p < 0.001). Predictors of not using iodine supplement in Eastern and Western Denmark were short maternal education, non-Danish origin and pre-pregnancy obesity.
CONCLUSIONS: The iodine status in Danish pregnant women was below WHO recommendations. Iodine supplement non-users are at a particular risk of iodine deficiency. Low maternal education, non-Danish origin and pre-pregnancy obesity are predictors of non-iodine supplement use. An increase in iodine fortification may be recommended to improve the iodine status in pregnant Danish women. FUNDING: none. TRIAL REGISTRATION: not relevant.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27808034

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  7 in total

1.  Risk-Benefit Assessment of an Increase in the Iodine Fortification Level of Foods in Denmark-A Pilot Study.

Authors:  Lea Sletting Jakobsen; Josefine Ostenfeld Nielsen; Sophie Egesø Paulsen; Malene Outzen; Allan Linneberg; Line Tang Møllehave; Tue Christensen; Gitte Ravn-Haren
Journal:  Foods       Date:  2022-04-28

2.  Assessment of iodine fortification of salt in the Danish population.

Authors:  Malene Outzen; Cecilie E Lund; Tue Christensen; Ellen Trolle; Gitte Ravn-Haren
Journal:  Eur J Nutr       Date:  2022-03-21       Impact factor: 4.865

3.  Iodine adequacy in reproductive age and pregnant women living in the Western region of Saudi Arabia.

Authors:  Firas Azzeh; Bassem Refaat
Journal:  BMC Pregnancy Childbirth       Date:  2020-06-22       Impact factor: 3.007

4.  Iodine nutrition status and thyroid autoimmunity during pregnancy: a cross-sectional study of 4635 pregnant women.

Authors:  Xiao Chen; Chunfeng Wu; Zhengyuan Wang; Chunxiang Wu; Yan Guo; Xiaoxia Zhu; Yan Ping Hu; Zehuan Shi; Qi Song; Xueying Cui; Jin Su; Jiajie Zang
Journal:  Nutr J       Date:  2022-01-29       Impact factor: 3.271

5.  Pregnant Dutch Women Have Inadequate Iodine Status and Selenium Intake.

Authors:  K Clara Mayunga; Melany Lim-A-Po; Janniek Lubberts; Eline Stoutjesdijk; Daan J Touw; Frits A J Muskiet; D A Janneke Dijck-Brouwer
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

6.  Iodine Deficiency in Zhejiang Pregnant Women in the Context of Universal Salt Iodization Programme.

Authors:  Zhifang Wang; Mingluan Xing; Wenming Zhu; Guangming Mao; Zhe Mo; Yuanyang Wang; Zhijian Chen; Xiaoming Lou; Shichang Xia; Xiaofeng Wang
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

Review 7.  Nutrients in Fish and Possible Associations with Cardiovascular Disease Risk Factors in Metabolic Syndrome.

Authors:  Christine Tørris; Milada Cvancarova Småstuen; Marianne Molin
Journal:  Nutrients       Date:  2018-07-23       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.